Pharmacologia  Volume 4 Issue 6, 2013

Review Article

Prunella vulgaris L. : A Literature Review on its Therapeutic Potentials
Rafia Rasool
Department of Biochemistry, University of Kashmir, Srinagar-190006, Jammu and Kashmir, India

Bashir A. Ganai
Department of Biochemistry, University of Kashmir, Srinagar-190006, Jammu and Kashmir, India

The phytotherapeutic approach is one of the ways for modern drug development and many synthetic drugs are being developed on the prototype analogues isolated from plant bioactive principles. One of such widely used plants is self-heal (Prunella vulgaris L.), an ancient therapy used for pain in the throat, fevers and accelerating wound healing. The different health benefits of P. vulgaris for a wide variety of diseases, including cancers, viral and inflammatory diseases, were recently reported. Many of these effects of P. vulgaris are related to the presence of rosamarinic acid, betulinic acid, prunellin and many other bioactive principles which make the plant interesting for antiviral, immunomodulatory and antiproliferative studies. This article provides a review of the data of this commonly used medicinal plant in number of countries. And in addition directs us for judicious use of such valuable species under scientific supervision so as to yield maximum health benefits.
    How to Cite:
Rafia Rasool and Bashir A. Ganai , 2013. Prunella vulgaris L. : A Literature Review on its Therapeutic Potentials. Pharmacologia, 4: 441-448
DOI: 10..5567/pharmacologia.2013.441.448

P. vulgaris L. (Labiatae), a rediscovered herb belonging to the mint family also known as self heal, was very popular in European, Asian and Chinese medicine and was used against fever, wounds and throat infections1. Its flowering season is from May to September2. For this reason the herb in Chinese is known as “Xia Ku Cao”, meaning “Grass perished at the end of summer”. The flowers are hermaphrodite3. This 1-2 feet high medicinal herb grows on grassland and usually prefers acidic, neutral and basic soils. It grows in semi shade or moist soil4. “Prunella” was derived from German word “Brunellen” which means “inflammation of mouth” as it was used by German military physicians for treatment of contagious fever characterized with sore throat and a brown-coated tongue among the troops in 1547 and 1566 ( The epithet of the species “vulgaris” is from the Latin adjective “vulgar” meaning “common” as the plant is widespread. John Gerard’s book “Herball” in 1597 mentioned that there was no "better wound herb" in the world than Self Heal". The great herbalist, Nicholas Culpepper, wrote that "Self Heal" if taken both "inwardly or outwardly for wounds and bleeding" would "cleanse the foulness of sores and heal them.

General health benefits of Prunella vulgaris: Dried fruit spikes with flowers are used for various pharmaceutical purposes, besides leaves and stems are used for olive green dye. Leaves are used as raw or cooked in salads and soups5. Fresh leaves and stem of herb are rich in protein, plant fat, carbohydrate, carotene, vitamin B and nicotinic acid5. The whole plant is considered as alterative, antibacterial, antipyretic, antiseptic, antispasmodic, astringent, carminative, diuretic, febrifuge, hypotensive, stomachic, styptic, tonic, vermifuge and vulnerary 6,7. It was used to heal wounds, ulcers and sores8. It was used as a tea in treatment of fevers, diarrhoea, sore mouth and internal bleeding9. It is antibiotic and hypotensive9.

Composition: The most active constituents reported in this herb were betulinic-acid, D-camphor, delphinidin, hyperoside, manganese, oleanolic-acid, rosmarinic-acid, rutin, ursolic-acid, tannins volatile oil, beta-carotene, sugar, cellulose, vitamins B-1, C and K3. A triterpene, 2α, 3α, 24-trihydroxyolean-12-en-28-oic acid was found in the leaves and stems of P. vulgaris10. Three pentacyclic triterpenes were isolated from the roots of P. vulgaris11. Again two hexacyclic triterpenoids (12R,13S)-2α, 3α, 24-trihydroxy-12,13-cyclotaraxer-14-en-28-oic acid and (13S,14R)-2α, 3α, 24-trihydroxy-13,14-cyclo-olean-11-en-28-oic acid as methyl esters were isolated from the roots of plant as well12. Ursolic acid and its derivatives were also reported in the herb13. Prunellin, an anti-HIV polysaccharide was isolated from aqueous extracts of P. vulgaris14. The molecular size of prunellin was about 10 kDa. Glucose, galactose, xylose, gluconic acid, galactonic acid and galactosamine were reported as the constituent monosaccharides14. Latter on four β-d-glucopyranosides (sitosterol, stigmasterol, stigmast-7-en-3β-ol and spinasterol) were identified15. Four novel triterpenes, i.e., betulinic acid, ursolic acid, 2α, 3α-dihydroxyurs-12-en-28-oic acid and 2α-hydroxyursolic acid were obtained by activity-guided fractionation of the P. vulgaris extract16. Fifteen triterpenoic acids, four flavonoids, four phenolics and a diterpene were isolated from MeOH extract of aerial parts of P. vulgaris var. Lilacina17. Oleanolic acid (OA) and Ursolic Acid (UA) in P. vulgaris were separated by modified HPLC18. Some novel depsides and two phenylpropanoids were isolated from the ethanol extract of the spikes of P. vulgaris i.e., Butyl rosmarinate, ethyl rosmarinate, methyl rosmarinate, rosmarinic acid, 3,4,α-trihydroxy-methyl phenylpropionate and p-coumaric acid19. Seven compounds from the spikes of P. vulgaris were isolated and their structures were established as autantiamide acetate, rhein, tanshinone I, danshensu, stigmast-7, 22-dien-3-one, 3, 4, alpha-trihydroxy-methyl phenylpropionate and butyl rosmarinate20. A novel triterpenoid saponin 16-oxo-17-demethyl-3beta, 24-dihydroxylolean-12-en-3-O-beta-D-glucuronoside (named as prunelloside A) and a flavones glycoside acacetin-7-O-beta-D-glucopyranoside were reported as constituents of P. vulgaris21. By using High Performance Liquid Chromatography (HPLC) and LC/MS analysis the main active compounds obtained were phenols, such as caffeic acid, rosmarinic acid, rutin and quercetin22. A new phenolic glycoside structurally elucidated as gentisic acid 5-O-beta-D-(6’-salicylyl)-glucopyranoside were obtained from the spikes of P. vulgaris23. Content of phenolic compounds in four species of Prunella (P. vulgaris, P. laciniata, P. grandiflora and P. orientalis) were reported as phenolic acids (rosmarinic acid, caffeic acid, ferulic acid, chlorogenic acid, protocatechuic acid), flavonoids (rutin, quercetin) in different quantitative proportions24. Again Oleanolic Acid (OA) was isolated from an ethanol extract of herb and its chemical structure was identified25.

Effect on mutagens: P. vulgaris was found to be anti mutagenic in nature inhibiting mutagenicity of benzopyrene26. Similarly P. vulgaris spikes when tested against the environmental mutagens and carcinogens like benzopyrene, 1, 6-dinitropyrene and 3, 9-dinitrofluoranthene were reported effective27.

Effect on different viral serotypes: Anti-HBsAg (Anti-Hepatitis B surface antigen) capability was reported in P.vulgaris28. The antiviral activity of this herb was screened qualitatively and quantitatively against Herpes simplex virus29. The crude extract of P. vulgaris, was able to effectively inhibit HIV-1 replication with relatively low cytotoxicity. The responsible active factor was purified and was anionic with a molecular weight of approximately 10 kDa30. Two triterpenes isolated from P. vulgaris as betulinic acid and 2α, 3α-dihydroxyurs-12-en-28-oic acid were reported with antiviral activity against Herpes simplex virus type 1. The antiviral activity was estimated as EC50= 30 and 8 μg mL-1, respectively by plaque reduction assay31. Further the anti-HIV-1 effects of the hot water extracts of P. vulgaris spikes was also reported. Their IC100 values were 16 μg mL-1 32. The ability of different dilutions of P. vulgaris extracts to inhibit replication of HIV strain H9/3B was monitored by inhibition of HIV-induced cytotoxicity in MT2 cells, measured by the MTT uptake assay33. The water soluble substance was isolated from P. vulgaris, by hot water extraction, ethanol precipitation and gel permeation column chromatography. Chemical tests showed that the component was an anionic polysaccharide. Using plaque reduction assay, the polysaccharide at 100 μg mL-1 was active against the Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), but was inactive against cytomegalovirus, the human influenza virus types A and B, the poliovirus type 1 or the vesicular stomatitis virus. The Prunella polysaccharide was not cytotoxic to mammalian cells up to the highest concentration tested, 0.5 mg mL-1 and has not showed any anti-coagulant activity34. The aqueous and methanol extracts were also reported for their in vitro inhibition on human immunodeficiency virus type-1 protease (HIV-1 PR). Among different herbal extracts examined, the aqueous extracts of P. vulgaris elicited inhibition (>90%) at a concentration of 200 μg mL-1, 35. The extract of P. vulgaris spikes were again reported to inhibit HIV replication at reverse transcription in vitro36. Potent HIV-1 inhibitory activity was observed in aqueous extract of P. vulgaris37. A polysaccharide fraction was found in P. vulgaris that showed its effects on the expressions of HSV-1 and HSV-2 antigens. The effective concentrations of extract with 50% reductions of the HSV-1 and HSV-2 antigens were 20.6 and 20.1 μ mL-1, respectively38. Multiple P. vulgaris constituents were indicated to have profound anti-viral activity against Equine Infectious Anaemia Virus (EIAV), providing evidence of the anti-viral abilities of its extracts. Aqueous extracts prevented entry of viral particles into permissive cells suggesting that these extracts may function as promising microbicides against Lentiviruses39. Aqueous extracts of P. vulgaris were reported to display potent antiviral activity against HIV-1 infection than ethanol extracts. Extract inhibited both virus/cell interactions and post- virion binding events40. In another study anti-HSV compound from P. vulgaris was identified as lignin-polysaccharide (PPS-2b) complex having a molecular weight of 8500 with strong activity against HSV-1 and HSV-2 and its mode of action is inhibiting viral binding and penetration into host cells41.

Effect on cell proliferation: The organic fraction (25.7% w/w of rosmarinic acid) of P. vulgaris displayed antiproliferative effects against HaCaT cells and mouse epidermal fibroblasts42. Rosmarinic acid was isolated from the methanolic extract of P. vulgaris which showed inhibitory activity against Lymphocyte Cell-specific Kinase (Lck) Src-Homology 2 (SH2) binding to a synthetic phosphotyrosine-containing peptide (phosphopeptide) of hamster polyomavirus middle-sized tumor (hmT pY324). The IC50 value for Lck SH2 binding to phosphopeptide was 7 μM43. P. vulgaris extracts was reported to suppress the proliferation in Raji cells and may be a new anti-lymphoma drug. Immunocytochemistry showed that after Raji cells were treated by the injection of P. vulgaris (50 mg mL-1) for 48 h, the expression of bcl-1 was up-regulated and the expression of bax was down-regulated44. P. vulgaris displayed significant antiestrogenic activity against endometrial cancer cell line, ECC-145. A phenolic components in P. vulgaris ethanolic extract was reported to significantly inhibit the tumor growth in C57BL/6 mice22. Chemoprevention by P. vulgaris 60% ethanol extract (P-60) was again reported against non-small cell lung cancer via promoting apoptosis in SPC-A-1 cells and regulating the cell cycle46. Two polysaccharides (P31 and P32) were isolated from the aqueous extract of herb. The main monosaccharide composition of polysaccharide P32 consisted of rhamnose, arabinose, xylose, mannose, glucose and galactose in a molar ratio of 3.46: 49.32: 58.91: 0.43: 2.64: 3.11, respectively. Polysaccharides showed anti-lung cancer activity in a C57BL/6 mouse-Lewis Lung cCarcinoma (LLC) model that increased the thymus index and the spleen index47. Oleanolic acid was isolated from P. vulgaris ethanolic extract that induced apoptosis in lung adenocarcinoma SPC-A-1 cell line through down-regulating Bcl-2 expression and up-regulating Bax and Bad expression. Oleanolic acid at 16 and 8 μM increased the apoptosis rate compared to normal25. Aqueous extract of P. vulgaris was reported to affect migration and invasion of human liver carcinoma cells by inhibiting activities of metalloproteases, MMP-2 and MMP-9, without affecting cell viabilities48. A strong inhibitory effect of P. vulgaris was observed on growth of two lung adenocarcinoma cell lines A549 and SPC-A-1. Inhibition rate of lung tumor deterioration by high dosage of extract was 3.56±6.79% and low dosage was 33.45±10.98%. Furthermore, it enhanced thymus index whereas no effect was observed on spleen index in tumor-bearing mice. The content of TNF-α in serum was increased in P. vulgaris group hence P. vulgaris was reported to possess the prevention effects on lung cancer49. Different concentrations of the extract from P. vulgaris were found to inhibit the proliferation of both Raji and Jurkat cells and with the increase of the concentration of the extract the early cell apoptosis rate was increased and the expression of BCL-2 protein was down-regulated and BAX up-regulated50.

Effect on oxidative stress: Significant antioxidative activitiy was found in hydroalcholic extract of P. vulgaris51. The antioxidative activity was partly with regard to the rosmarinic acid content. Antioxidative activity against superoxide, hydroxyl radicals and pro-oxidants were reported52. Furthermore it was reported that P. vulgaris extract exhibited scavenging activity on diphenylpicrylhydrazyl radical (DPPH), inhibited in vitro human LDL Cu (II)-mediated oxidation, protected rat mitochondria and rat hepatocytes exposed to either tert-butyl hydroperoxide, or to Cu(II) and Fe(III) ions. Extract also inhibited rat erythrocyte haemolysis and reduced the production of LTB in bovine PMNL generated by the 5-lipoxygenase pathway42. The positive effect of phenolics-rich extract of P. vulgaris was observed on blood, liver antioxidant status and lipoprotein metabolism. It affected plasma lipoprotein profile in an experimental animal model with induced dietary hypertriglyceridemia53. The P. vulgaris extract and its main phenolic acid component, rosmarinic acid significantly suppressed UVA-induced ROS production in a human keratinocyte cell line (HaCaT), which indicated a decrease in intracellular lipid peroxidation54. P. vulgaris aqueous extract was evidenced to inhibit mast cell-derived immediate-type allergic reactions, proinflammatory cytokines and nuclear factor-kappa B. Extract (0.001-0.1 g kg-1) dose dependently inhibited compound I nduced systemic anaphylaxis and serum histamine release in mice. It also decreased the IgE-mediated local allergic reaction, passive cutaneous anaphylaxis. In addition, extract attenuated phorbol 12-myristate 13-acetate (PMA) and calcium ionophore A23187-stimulated TNF-alpha, IL-6 and IL-8 secretion in human mast cells55. Ethanolic extract of the spikes of P. vulgaris was reported to yield two ursane-type triterpenes 3beta,23-dihydroxyurs-12-en-28-oic acid (23-hydroxyursolic acid) and 3beta-hydroxyurs-12-en-28-oic acid (ursolic acid) which protected cells against oxidant-mediated injury. Treatment with these compounds increased the expression of inducible heme oxygenase (HO)-1 enzyme in human liver-derived HepG2 cells56.

Effect on inflammation: SKI 306X was extracted from a mixture of three herbal medicines Clematis mandshurica, Trichosanthes kirilowii and P. vulgaris that have been widely used for the treatment of inflammatory diseases such as lymphadenitis and arthritis57. Anti-inflammatory activity in one of the polysaccharide fraction PV21V of herb was reported58. Water extracts of P. vulgaris was reported for anti-inflammatory activity. Extract stimulated the proliferation of T-lymphocytes and suppressed NO production in lipopolysaccharide-stimulated macrophages dose dependently without any cytotoxicity59. The anti-inflammatory effect was also observed in aqueous extract of P. vulgaris via inhibition of ROS/NF-κB pathway by inducing HO-1 and eNOS expression mediated by Nrf2, thereby suggesting that herb may be a possible remedy for inhibition of diabetic vascular diseases60. Anti-inflammatory activity of ethanol extract by inducing heme oxygenase-1 (HO-1) expression through PI3K/Nrf2 signal pathways was reported, which may be good for the treatment of sepsis because of decrease in high mobility group box?1(HMGB1) release, a cytokine released in late phase in sepsis61.

Antimicrobial activity: P. vulgaris decoction showed strong inhibition and control on diarrhea bacilli, salmonella typhi, Vibrio cholerae, E.coli, Proteus vulgaris, Staphylococcus aureus and Mycobacterium tuberculosis. Morever alcoholic decoction of P. vulgaris showed inhibition on Pseudomonas aeruginosa, water decoction showed inhibition on fungi. It also inhibits Pseudomonas, Bacillus typhi, E.coli, Mycobacterium tuberculosis6. The rosmarinic acid of P. vulgaris was found to exhibit a moderate antimicrobial activity on gram-positive bacteria42. The antimicrobial effects exhibited by plant polysaccharide was also reported58. Antibacterial activity of the methanolic extract of P. vulgaris extracts was reported against Escherichia coli, Staphylococcus aureus, Salmonella typhimurium and Kleibsella pneumonae62. Two polyacetylenic acids were isolated from P. vulgaris methanolic extract as active principles and were identified as octadeca-9,11,13-triynoic acid and trans-octadec-13-ene-9,11-diynoic acid. These two compounds inhibited the growth of fungal pathogens Magnaporthe oryzae, Rhizoctonia solani, Phytophthora infestans, Sclerotinia sclerotiorum, Fusarium oxysporum f. sp. Raphani and Phytophthora capsici. The n-hexane fraction of P. vulgaris significantly suppressed the development of rice blast, tomato late blight, wheat leaf rust and red pepper anthracnose63. The effect of the extract of P. vulgaris on Multiple Drugs Resistant Bacillus Tuberculosis (MDR-TB) was reported and the extract could enhance the cellular immunological function in rats by up-regulating level of genetic transcription which provided the basis of healing of MDR-TB with it64. Purified homodimer of lectin showed significant antimicrobial activity against Salmonella typhi, Klebseilla pnuemonea and Escherhia coli65.

Effect on cardiovascular diseases: The cardioprotective effect of ethylacetate fraction and its constituent rosamarinic acid of P. vulgaris were reported on rats induced with oxidative stress66. Positive control used were less effective. The effect on eNOS gene expression of P. vulgaris was observed with favourable effects on the vasculature and could have therapeutic potential against cardiovascular diseases by acting as potent eNOS-upregulating agent 67.

Cosmetics: The plant extract or its saponin was reported to be used for the preparation of a cosmetic or pharmaceutical and dermatological composition. Composition of this herb helped to regulate the renewal and differentiation of the keratinocytes and has an anti-ageing activity, especially in inflammations caused by ultraviolet radiations68. The potency of P. vulgaris extract and its main phenolic acid component, Rosmarinic Acid (RA), was found to suppress UVB-induced (295 to 315 nm) skin damage to human keratinocytes HaCaT cells. Extract (5 to 50 mg L-1) and RA (0.18 to 1.8 mg L-1) reduced breakage together with the apoptotic process in cells. Extract and RA also eliminated ROS production and diminished IL-6 release69.

Effect on teeth: Herbal-based dentifrice i.e., P. vulgaris extract was reported to be effective in reducing symptoms of gingivitis70. P. vulgaris extract and rosamarnic acid was able to suppress LPS-induced biological changes in gingival fibroblasts by modulating the inflammation process in periodontal disease71.

Effect on immune system: The immonosupressive activity of the ethanol extract of spica prunellae on the immune response in mice was studied72. One of Polysaccharide fraction PV21V up-regulated the immune response of monocytes58. Again investigation showed that water extracts of P. vulgaris extract stimulated the proliferation of T-lymphocytes and suppressed NO production in lipopolysaccharide-stimulated59. The immunostimulatory and antitumor activity of P. vulgaris in murine macrophage RAW 264.7 cells was reported. Plants extract stimulated macrophage phagocytic activity, Nitric Oxide (NO) production and cytostatic activity. In addition induced gene expression and production of macrophage-related cytokines such as TNF-α, IL-1 β and IL-673. Rosmarinic acid in ethanol extract of plant inhibited lipopolysaccharide-induced prostaglandin E2 and nitric oxide in RAW 264.7 mouse macrophages74. 0.1 and 1.0% doses of P. vulgaris extracts augmented diets increased the non-specific immune response and disease resistance of P. olivaceus against U. Marinum75.

Anti-allergic: The effect of aqueous extract of herb on immediate-type allergic reactions was studied which showed that extract (0.005 to 1 g kg-1) inhibited systemic anaphylactic shock in rats. When extract was given at concentrations ranging from 0.005 to 1 g kg-1, the serum histamine levels were also reduced76. Again the effect of aqueous extract of P. vulgaris on the mast cell-mediated allergy model was investigated and it was found that extract (0.001 to 0.1 g kg-1) dose dependently inhibited systemic anaphylaxis and serum histamine release in mice55.

Anti-diabetic: P. vulgaris extract at dose of 100 mg kg-1 significantly suppressed the rise in blood glucose after 30 min in the acute glucose tolerance test. It enhanced the antihyperglycemic effects of exogenous insulin without stimulating insulin secretion in streptozotocin-induced diabetic mice77. Extract also has a protective effect on IL-1β-induced INS-1 cell apoptosis. It attenuates IL-1β-increased NF-κB binding activity and inflammatory cytokine expression in INS-1 pancreatic β-cells. PVAE may have a benefit for type I diabetic patients78.

Antistress: The ability of ethanolic extract of leaves of P. vulgaris to prolong the swimming time and ameliorate the stress induced changes in animal stress models was reported, therefore suggested its adaptogenic property79.

Various laboratory in vitro and in vivo studies have shown the health effects of this herb, but the human clinical evidence is still limited, future research is needed to actually define the different benefits particularly for the ailments like viral diseases and cancers where synthetic drugs are not effective because of lesser safety margin and higher cost. Health benefits of the different bioactive principles need to be evaluated more.


  1. Markova, H., J. Sousek and J. Ulrichova, 1997. Prunella vulgaris L.: A rediscovered medicinal plant. Ceska Slov. Farm., 46: 58-63

  2. Grieve, M., 1984. A Modern Herbal. Penguin Publishers, USA.

  3. Jackson, D. and K. Bergeron, 2006. Plant profile of Prunella vulgaris L.

  4. Chittendon, F., 1956. RHS Dictionary of Plants Plus Supplements. Oxford University Press, Oxford, UK.

  5. Launert, E., 1981. Edible and Medicinal Plants of Britain and Northern Europe. Hamlyn, Twickenham, ISBN: 0-600-37216-2.

  6. Yeung, H.C., 1985. A Handbook of Chinese Herbs and Formulas. Institute of Chinese Medicine, Los Angeles, USA.

  7. Duke, J.A. and E.S. Ayensu, 1985. Medicinal Plants of China. Reference Publications, Michigan, USA.

  8. Chiej, R., 1984. Encyclopaedia of Medicinal Plants. 1st Edn., MacDonald, London, ISBN: 0-356-10541-5.

  9. Foster, S. and J.A. Duke, 1990. A Field Guide to Medicinal Plants. Houghton Mifflin Co., New York, USA.

  10. Kojima, H. and H. Ogura, 1986. Triterpenoids from Prunella vulgaris. Phytochemistry, 25: 729-733

  11. Kojima, H., H. Tominaga, S. Sato and H. Ogura, 1987. Pentacyclic triterpenoids from Prunella vulgaris. Phytochemistry, 26: 1107-1111

  12. Kojima, H., H. Tominaga, S. Sato, H. Takayanagi and H. Ogura, 1988. Two novel hexacyclic triterpenoids from Prunella vulgaris. Phytochemistry, 27: 2921-2925

  13. Lee, H. and J.Y. Lin, 1988. Antimutagenic activity of extracts from anticancer drugs in Chinese medicine. Mutation Res./Genet. Toxicol., 204: 229-234

  14. Tabba, H.D., S.R. Chang and K.M. Smith, 1989. Isolation, purification and partial characterization of prunellin, an anti-HIV component from aqueous extracts of Prunella vulgaris. Antiviral Res., 11: 263-273

  15. Kojima, H., N. Sato, A. Hantano and H. Ogura, 1990. Sterol glucosides from Prunella vulgaris. Phytochemistry, 29: 2351-2355

  16. Ryu, S.Y., M.H. Oak, S.K. Yoon, D.I. Cho, G.S. Yoo, T.S. Kim and K.M. Kim, 2000. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med., 66: 358-360

  17. Lee, I.K., D.H. Kim, S.Y. Lee, K.R. Kim and S.U. Choi et al., 2008. Triterpenoic acids of Prunella vulgaris var. lilacina and their cytotoxic activities in vitro. Arch. Pharm. Res., 31: 1578-1583

  18. Du, H. and X.Q. Chen, 2009. A comparative study of the separation of oleanolic acid and ursolic acid in Prunella vulgaris by high-performance liquid chromatography and cyclodextrin-modified micellar electrokinetic chromatography. J. Iran. Chem. Soc., 6: 334-340

  19. Wang, Z.J., Y.Y. Zhao, B. Wang, A.T. Min, Y. Yan and Y.Y. Chen, 2000. Depsides from Prunella vulgaris. Chinese Chem. Lett., 11: 997-1000.

  20. Gu, X.J., Y.B. Li, P. Li, S.H. Qian and J.A. Duan, 2007. Studies on chemical constituents of Prunella vulgaris. Zhongguo Zhong Yao Za Zhi, 32: 923-926

  21. Zhang, L.Z., Y.J. Guo, G.Z. Tu, R.B. Shi, W. Qin, Y.Y. Ba and F. Yang, 2008. A novel triterpenoid saponin from Prunella vulgaris. Yao Xue Xue Bao, 43: 169-172 [Article in Chinese]

  22. Feng, L., X. Jia, M. Zhu, Y. Chen and F. Shi, 2010. Chemoprevention by Prunella vulgaris L. extract of non-small cell lung cancer via promoting apoptosis and regulating the cell cycle. Asian Pac. J. Cancer Prev., 11: 1355-1358

  23. Gu, X.J., Y.B. Li, J. Mu and Y. Zhang, 2011. A new phenolic glycoside from Prunella vulgaris. Yao Xue Xue Bao., 46: 561-563

  24. Sahin, S., C. Demir and H. Malyer, 2011. Determination of phenolic compounds in Prunella L. by liquid chromatography-diode array detection. J. Pharm. Biomed. Anal., 55: 1227-1230

  25. Feng, L., W. Au-Yeung, Y.H. Xu, S.S. Wang, Q. Zhu and P. Xiang, 2011. Oleanolic acid from Prunella vulgaris L. induces SPC-A-1 cell line apoptosis via regulation of Bax, Bad and Bcl-2 expression. Asian Pac. J. Cancer Prev., 12: 403-408

  26. Lee, K.H., Y.M. Lin, T.S. Wu, D.C. Zhang and T. Yamagishi et al., 1988. The cytotoxic principles of Prunella vulgaris, Psychotria serpens and Hyptis capitata: Ursolic acid and related derivatives. Planta Med., 54: 308-311

  27. Horikawa, K., T. Mohri, Y. Tanaka and H. Tokiwa, 1994. Moderate inhibition of mutagenicity and carcinogenicity of benzo[a]pyrene, 1,6-dinitropyrene and 3,9-dinitrofluoranthene by Chinese medicinal herbs. Mutagenesis, 9: 523-526

  28. Zheng, M.S. and Z.Z. Zhang, 1990. Anti-HBs-Ag herbs employing ELISA technique. Zhong Xi Yi Jie He Za Zhi., 10: 560-562 [Article in Chinese]

  29. Zheng, M., 1990. Experimental study of 472 herbs with antiviral action against the herpes simplex virus. Zhong Xi Yi Jie He Za Zhi, 10: 39-41

  30. Yao, X.J., M.A. Wainberg and M.A. Parniak, 1992. Mechanism of inhibition of HIV-1 infection In vitro by purified extract of Prunella vulgaris. Virology, 187: 56-62

  31. Ryu, S.Y., C.K. Lee, O.C. Lee, H.S. Kim and O.P. Zee, 1992. Antiviral triterpenes from Prunella vulgaris. Arch. Pharm. Res., 15: 242-245

  32. Yamasaki, K., T. Otake, H. Mori, M. Morimoto and N. Ueba et al., 1993. Screening test of crude drug extract on anti-HIV activity. Yakugaku Zasshi, 113: 818-824

  33. John, J.F., R. Kuk and A. Rosenthal, 1994. Synergistic antiretroviral activities of the herb, Prunella vulgaris with AZT, ddI and ddC. Abstr Gen. Meet Am. Soc. Microbiol., 94: 481-481

  34. Xu, H.X., S.H.S. Lee, S.F. Lee, R.L. White and J. Blay, 1999. Isolation and characterization of an anti-HSV polysaccharide from Prunella vulgaris. Antiviral Res., 44: 43-54

  35. Lam, T.L., M.L. Lam, T.K. Au, D.T.M. Ip, T.B. Ng, W.P. Fong and D.C.C. Wan, 2000. A comparison of human immunodeficiency virus type-1 protease inhibition activities by the aqueous and methanol extracts of Chinese medicinal herbs. Life Sci., 67: 2889-2896

  36. Kageyama, S., M. Kurokawa and K. Shiraki, 2000. Extract of Prunella vulgaris spikes inhibits HIV replication at reverse transcription In vitro and can be absorbed from intestine In vivo. Antiviral Chem. Chemother., 11: 157-164

  37. Liu, S., S. Jiang, Z. Wu, L. Lv, J. Zhang, Z. Zhu and S. Wu, 2002. Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte. Life Sci., 71: 1779-1791

  38. Chiu, L.C.M., W. Zhu and V.E.C. Ooi, 2004. A polysaccharide fraction from medicinal herb Prunella vulgaris down regulates the expression of herpes simplex virus antigen In vero cells. J. Ethnopharmacol., 93: 63-68

  39. Brindley, M.A., M.P. Widrlechner, J.A. McCoy, P. Murphy and C. Hauck et al., 2009. Inhibition of lentivirus replication by aqueous extracts of Prunella vulgaris. Virol. J., Vol. 6. 10.1186/1743-422X-6-8

  40. Oh, C., J. Price, M.A. Brindley, M.P. Widrlechner and L. Qu et al., 2011. Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L. Virol. J., 8: 188-197

  41. Zhang Y., P.P. But, V.E. Ooi, H.X. Xu, G.D. Delaney, S.H. Lee and S.F. Lee, 2007. Chemical properties, mode of action and in vivo anti-herpes activities of a lignin-carbohydrate complex from Prunella vulgaris. Antiviral Res., 75: 242-249.

  42. Psotova, J., M. Kolar, J. Sousek, Z. Svagera, J. Vicar and J. Ulrichova, 2003. Biological activities of Prunella vulgaris extract. Phytother. Res., 17: 1082-1087

  43. Ahn, S.C., W.K. Oh, B.Y. Kim, D.O. Kang, M.S. Kim, G.Y. Heo and J.S. Ahn, 2003. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide. Planta Med., 69: 642-646

  44. Zhang, K.J., M.Z. Zhang, Q.D. Wang and W.L. Liu, 2006. The experimental research about the effect of Prunella vulgaris L. on Raji cells growth and expression of apoptosis related protein. Zhong Yao Cai, 29: 1207-1210

  45. Collins, N.H., E.C. Lessey, C.D. DuSell, D.P. McDonnell and L. Fowler et al., 2009. Characterization of antiestrogenic activity of the Chinese herb, Prunella vulgaris, using In vitro and In vivo (Mouse Xenograft) models. Biol. Reprod., 80: 375-383

  46. Feng, L., X. Jia, M.M. Zhu, Y. Chen and F. Shi, 2010. Antioxidant activities of total phenols of Prunella vulgaris L. in vitro and in tumor-bearing mice. Molecules, 15: 9145-9156

  47. Feng, L., X.B. Jia, F. Shi and Y. Chen, 2010. Identification of two polysaccharides from Prunella vulgaris L. and evaluation on their anti-lung adenocarcinoma activity. Molecules, 15: 5093-5103

  48. Kim, S.H., C.Y. Huang, C.Y. Tsai, S.Y. Lu, C.C. Chiu and K. Fang, 2012. The aqueous extract of Prunella vulgaris suppresses cell invasion and migration in human liver cancer cells by attenuating matrix metalloproteinases. Am. J. Chin. Med., 40: 643-656

  49. Jia, X., L. Feng, Y. Chen, G. Liu and F. Shi, 2010. Prevention and Immunomodulation Activity of Prunella vulgaris L. on Lung Cancer. In: Recent Advances in Clinical Medicine, Anninos, P., M. Rossi, T.D. Pham, C. Falugi, A. Bussing and M. Koukkou (Eds.). World Scientific and Engineering Academy and Society Press, UK., pp: 267-272.

  50. Fu, X.R., Z.C. Sun and M.Z. Zhang, 2012. Experimental study of extract from Prunella vulgaris inducing B, T lymphoma cell apoptosis. Zhong Yao Cai, 35: 433-438

  51. Lamaison, J.L., C. Petitjean-Freytet and A. Carnat, 1991. Medicinal lamiaceae with antioxidant properties, a potential source of rosmarinic acid. Pharmaceutica Acta Helvetiae, 66: 185-188

  52. Liu, F. and T.B. Ng, 2000. Antioxidative and free radical scavenging activities of selected medicinal herbs. Life Sci., 66: 725-735

  53. Skottova, N., L. Kazdova, O. Oliyarnyk, R. Vecera, L. Sobolova and J. Ulrichova, 2004. Phenolics-rich extracts from Silybum marianum and Prunella vulgaris reduce a high sucrose diet induced oxidative stress in hereditary hyperglyceridemic rats. Pharmacol. Res., 50: 123-130.

  54. Psotova, J., A. Svobodova, H. Kolarova and D. Walterova, 2006. Photoprotective properties of Prunella vulgaris and rosmarinic acid on human keratinocytes. J. Photochem. Photobiol. B Biol., 84: 167-174

  55. Kim, S.Y., S.H. Kim, H.Y. Shin, J.P. Lim and B.S. Chae et al., 2007. Effects of Prunella vulgaris on mast cell-mediated allergic reaction and inflammatory cytokine production. Exp. Biol. Med., 232: 921-926

  56. Jeong, G.S., R.B. An, H.O. Pae, G.S. Oh, H.T. Chung and Y.C. Kim, 2008. Heme oxygenase-1 inducing constituent of Prunella vulgaris in HepG2 cells. Biol. Pharm. Bull., 31: 531-533

  57. Jung, Y.B., K.J. Roh, J.A. Jung, K. Jung and H. Yoo et al., 2001. Effect of SKI 306X, a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee: A double-blind placebo controlled study. Am. J. Chinese Med., 29: 485-491

  58. Fang, X., R.C. Chang, W.H. Yuen and S.Y. Zee, 2005. Immune modulatory effects of Prunella vulgaris L. Int. J. Mol. Med., 15: 491-496

  59. Harput, U.S., I. Saracoglu and Y. Ogihara, 2006. Effects of two Prunella species on lymphocyte proliferation and nitric oxide production. Phytother. Res., 20: 157-159

  60. Hwang, S.M., Y.J. Lee, J.J. Yoon, S.M. Lee, J.S. Kim, D.G. Kang and H.S. Lee, 2012. Prunella vulgaris suppresses HG-induced vascular inflammation via Nrf2/HO-1/eNOS activation. Int. J. Mol. Sci., 13: 1258-1268

  61. Jun, M.S., H.S. Kim, Y.M. Kim, H.J. Kim and E.J. Park et al., 2012. Ethanol extract of Prunella vulgaris var. lilacina inhibits HMGB1 release by induction of heme oxygenase-1 in LPS-activated RAW 264.7 cells and CLP-induced septic mice. Phytother. Res., 26: 605-612

  62. Rasool, R., B.A. Ganai, A.N. Kamili, S. Akbar and A. Masood, 2010. Antioxidant and antibacterial activities of extracts from wild and in vitro-raised cultures of Prunella vulgaris L. Med. Aromatic Plant Sci. Biotechnol., 4: 20-27.

  63. Yoon, M.Y., G.J. Choi, Y.H. Choi, K.S. Jang, M.S. Park, B. Cha, J.C. Kim, 2010. Effect of polyacetylenic acids from Prunella vulgaris on various plant pathogens. Lett. Appl. Microbiol., 51: 511-517

  64. Lu, J., R. Qin, S. Ye and M. Yang, 2011. Prunella vulgaris L. extract improves cellular immunity in MDR-TB challenged rats. J. Med. Colleges PLA., 26: 230-237

  65. Wani, I.H., M.A.M. Sakeena, S. Rafiq, S.A. Ganie and M. Khan et al., 2011. Isolation and Partial Characterization of a Lectin from Prunella vulgaris and Evaluation of Its Potential Antimicrobial Activity. J. Pharm. Res., 4: 3531-3534

  66. Psotova, J., S. Chlopcikova, P. Miketova and V. Simanek, 2005. Cyto-protectivity of Prunella vulgaris on doxorubicin-treated rat cardiomyocytes. Fitoterapia, 76: 556-561

  67. Xia, N., L. Bollinger, K. Steinkamp-Fenske, U. Forstermann and H. Li, 2010. Prunella vulgaris L. upregulates eNOS expression in human endothelial cells. Am. J. Chin. Med., 38: 599-611

  68. Bonte, F., A. Meybeck and M. Dumas, 1997. Cosmetic or pharmaceutical composition containing a Prunella extract. United States Patent. No:5,624,673, Pub No: W092:21322.

  69. Vostalova, J., A. Zdarilova and A. Svobodova, 2010. Prunella vulgaris extract and rosmarinic acid prevent UVB-induced DNA damage and oxidative stress in HaCaT keratinocytes. Arch. Dermatol. Res., 302: 171-181

  70. Adamkova, H., J. Vicar, J. Palasova, J. Ulrichova and V. Simanek, 2004. Macleya cordata and Prunella vulgaris in oral hygiene products their efficacy in the control of gingivitis. Biomed Papers, 148: 103-105

  71. Zdarilova, A., A. Svobodova, V. Simanek and J. Ulrichova, 2009. Prunella vulgaris extract and rosmarinic acid suppress lipopolysaccharide-induced alteration in human gingival fibroblasts. Toxicol. In vitro, 23: 386-392

  72. Sun, H.X., F. Qin and Y.J. Pan, 2005. In vitro and In vivo immunosuppressive activity of Spica Prunellae ethanol extract on the immune responses in mice. J. Ethnopharmacol., 101: 31-36

  73. Han, E.H., J.H. Choi, Y.P. Hwang, H.J. Park and C.Y. Choi et al., 2009. Immunostimulatory activity of aqueous extract isolated from Prunella vulgaris. Food Chem. Toxicol., 47: 62-69

  74. Huang, N., C. Hauck, M.Y. Yum, L. Rizshsky and M.P. Widrlechner et al., 2009. Rosmarinic acid in Prunella vulgaris ethanol extract Inhibits Lipopolysaccharide-induced prostaglandin E2 and nitric oxide in RAW 264.7 mouse macrophages. J. Agric. Food Chem., 57: 10579-10589

  75. Harikrishnan, R., J.S. Kim, M.C. Kim, C. Balasundaram and M.S. Heo, 2011. Prunella vulgaris enhances the non-specific immune response and disease resistance of Paralichthys olivaceus against Uronema marinum. Aquaculture, 318: 61-66

  76. Shin, T.Y., Y.K. Kim and H.M. Kim, 2001. Inhibition of immediate-type allergic reactions by Prunella vulgaris in a murine model. Immunopharmacol. Immunotoxicol., 23: 423-435

  77. Zheng, J., J. He, B. Ji, Y. Li and X. Zhang, 2007. Antihyperglycemic activity of Prunella vulgaris L. in streptozotocin-induced diabetic mice. Asia Pac. J. Clin. Nutr., 16: 427-431

  78. Wu, H., M. Gao, T. Ha, J. Kelley, A. Young and K. Breuel, 2012. Prunella vulgaris aqueous extract attenuates IL-1β-induced apoptosis and NF-κB activation in INS-1 cells. Exp. Ther. Med., 3: 919-924

  79. Mrudula, G., P.M. Rao, K.N. Jayaveera, M.D. Arshad and S.A. Rehman, 2010. Antistress and antioxidant effects of Prunella vulgaris leaves. Pharmacologyonline, 2: 952-962.


Pharmacologia © 2019